Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body.
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA circulating in the blood.
7 hours ago
0
13
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Nov 25, 2025
0
114
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric cancer research, revealing how the "second brain"—nerves in the digestive system, also known as ...
Nov 25, 2025
0
7
Pancreatic cancer is the deadliest form of cancer worldwide, mainly because the disease is often discovered late. Symptoms associated with these tumors are often non-specific, so patients and doctors do not immediately suspect ...
Nov 21, 2025
0
0
A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic ...
Nov 20, 2025
0
1
The pancreas is essential for staying alive and healthy. This small organ sits behind the stomach and has two main jobs. It produces digestive enzymes that break down food and hormones such as insulin and glucagon that control ...
Nov 20, 2025
0
1
Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA—best known for being used in COVID-19 vaccines—in the hopes of finding a breakthrough treatment ...
Nov 20, 2025
0
0
Columbia University researchers are the first to show that focused ultrasound—a noninvasive technique that uses sound waves to enhance the delivery of drugs into the brain—can be safely used in children being treated ...
Nov 19, 2025
0
28
Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that effectively targets one of ...
Nov 18, 2025
0
1
Pancreatic cancer refers to a malignant neoplasm originating from transformed cells arising in tissues forming the pancreas. The most common type of pancreatic cancer, accounting for 95% of these tumors, is adenocarcinoma (tumors exhibiting glandular architecture on light microscopy) arising within the exocrine component of the pancreas. A minority arise from islet cells, and are classified as neuroendocrine tumors. The symptoms that lead to diagnosis depend on the location, the size, and the tissue type of the tumor. They may include abdominal pain and jaundice (if the tumor compresses the bile duct).
Pancreatic cancer is the fourth most common cause of cancer death across the globe. Pancreatic cancer often has a poor prognosis: for all stages combined, the 1- and 5-year relative survival rates are 25% and 6%, respectively; for local disease the 5-year survival is approximately 20% while the median survival for locally advanced and for metastatic disease, which collectively represent over 80% of individuals, is about 10 and 6 months respectively.
This text uses material from Wikipedia licensed under CC BY-SA
